United States Tissue Microarray Market Growth Opportunities & Industry Analysis | Major Market Players 2025 - Epredia, Novus Biologicals, OriGene Technologies

"Tissue Microarray Market is estimated to reach at a high CAGR during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/tissue-microarray-market?sp

United States

Recent Launches and Investments

✅ In July 2025, Leica Biosystems launched an advanced tissue microarray platform integrating high-throughput sample processing and AI-based analysis. The system targets research laboratories and pathology departments. It emphasizes efficiency, accuracy, and reproducibility in biomarker studies.

✅ In March 2025, Thermo Fisher Scientific invested $10 million in expanding its tissue microarray manufacturing and R&D facility. The initiative supports cancer research and drug development. It focuses on high-quality samples and standardized assay platforms.

Mergers and Acquisitions

✅ In June 2025, Bio-Techne acquired a U.S.-based tissue microarray technology startup to enhance its research tools portfolio. The acquisition strengthens R&D and product innovation. It targets pathology, oncology, and molecular research applications.

✅ In February 2025, Akoya Biosciences partnered with a microarray firm to co-develop next-generation tissue microarray platforms. The collaboration focuses on multiplexing, automation, and workflow efficiency. It supports translational research and diagnostics.

Japan

Recent Launches and Investments

✅ In May 2025, Sakura Finetek Japan launched a new tissue microarray system for high-throughput histopathology applications. The platform targets research institutes and clinical laboratories. It emphasizes precision, automation, and reproducibility.

✅ In January 2025, Sysmex Corporation invested $7 million in developing advanced tissue microarray technologies, focusing on cancer and biomarker research. The R&D supports automated processing and high-quality sample preparation. It targets clinical and academic research.

Mergers and Acquisitions

✅ In April 2025, Olympus Corporation acquired a Japanese tissue microarray startup to expand its pathology and imaging solutions portfolio. The acquisition strengthens innovation in sample processing and analysis. It supports research and diagnostic laboratories nationwide.

✅ In February 2025, Hamamatsu Photonics partnered with a domestic microarray technology firm to co-develop high-resolution tissue microarray imaging solutions. The collaboration focuses on multiplex analysis and workflow efficiency. It targets research and clinical pathology markets.

Tissue Microarray Market: Drivers

The tissue microarray (TMA) market is gaining prominence as researchers and diagnostic laboratories seek high-throughput solutions for analyzing multiple tissue samples simultaneously. TMA technology enables the examination of hundreds of tissue specimens on a single slide, allowing efficient biomarker discovery, cancer research, and drug development. Growing demand for personalized medicine and precision oncology is driving the adoption of tissue microarrays, as they facilitate rapid identification of molecular targets and disease patterns. Advances in automated tissue arrayers, imaging systems, and digital pathology platforms are enhancing the accuracy, reproducibility, and scalability of TMA applications. Additionally, integration with bioinformatics tools is supporting more comprehensive data analysis, enabling better insights into disease mechanisms and therapeutic responses.

Increasing prevalence of cancer and other chronic diseases is fueling the need for advanced tissue analysis techniques. Tissue microarrays allow researchers to conduct comparative studies across large patient cohorts, accelerating translational research and clinical validation of biomarkers. The growing emphasis on drug discovery, targeted therapies, and companion diagnostics is further expanding the use of TMAs in pharmaceutical and biotechnology sectors. Collaborative research initiatives and the expansion of academic and clinical laboratories are also driving market adoption. Overall, tissue microarray technology is transforming biomedical research and diagnostics by providing high-throughput, cost-effective, and precise solutions for understanding complex disease biology.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/tissue-microarray-market?sp

Tissue Microarray Market: Major Players

Epredia, Novus Biologicals, OriGene Technologies, Inc, ProteoGenex, PREMIER Biosoft, BioIVT, 3DHISTECH Ltd, US Biomax Inc., CD Genomics, Ted Pella, Inc

Segment Covered in the Tissue Microarray Market:

➥ By Procedure: Immunohistochemistry, Fluorescent in Situ Hybridization, In Situ Hybridization, Frozen Tissue Array, Others
➥ By Technology: DNA Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Others
➥ By Application: Oncology, Gene Expression Profiling, Comparative Genomic Hybridization, SNP Detection, Double-Stranded B-DNA Microarrays, Sequencing Bioinformatics, Others
➥ By End-User: Hospitals, Pharmaceutical & Biotechnological Companies, Research Organizations, Others

Research Process:

Both primary and secondary data sources have been used in the Tissue Microarray Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Tissue Microarray Market Research Industry:

➠ Who leads the Tissue Microarray industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Tissue Microarray market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Tissue Microarray market growth?
➠ What are the dominant sales and distribution strategies in the Tissue Microarray industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=tissue-microarray-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.